| Literature DB >> 14608321 |
Stephen Bridgman1, Lars Engebretsen, Katie Dainty, Alexandra Kirkley, Nicola Maffulli.
Abstract
Randomization and blinding are important tools in determining the effectiveness of a new intervention and ensuring the validity of a clinical trial. However, randomness and haphazardness are not equivalent. Randomization cannot overcome poor experimental design or technique. Several types of randomization including historical controls and pseudorandomization are discussed, as well as methods of treatment allocation, stratification, and minimization techniques. The importance of decreasing bias and the advantages and disadvantages of blinding in randomized clinical trials are also covered.Entities:
Mesh:
Year: 2003 PMID: 14608321 DOI: 10.1016/j.arthro.2003.09.023
Source DB: PubMed Journal: Arthroscopy ISSN: 0749-8063 Impact factor: 4.772